Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report)'s stock price gapped down before the market opened on Tuesday. The stock had previously closed at $14.74, but opened at $13.98. Reckitt Benckiser Group shares last traded at $13.97, with a volume of 10,448 shares traded.
Wall Street Analyst Weigh In
Several research firms have issued reports on RBGLY. The Goldman Sachs Group raised Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research note on Wednesday, October 7th. Zacks Research raised Reckitt Benckiser Group from a "strong sell" rating to a "hold" rating in a research report on Friday, August 28th. Jefferies Financial Group upgraded Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a report on Tuesday, July 21st. BNP Paribas Exane lowered Reckitt Benckiser Group from an "outperform" rating to a "neutral" rating in a research report on Wednesday, September 2nd. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Reckitt Benckiser Group in a research note on Tuesday, June 30th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy".
View Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Down 5.2%
The company has a debt-to-equity ratio of 1.31, a current ratio of 0.59 and a quick ratio of 0.40. The firm's 50 day simple moving average is $13.85 and its 200-day simple moving average is $14.21.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc, now operating under the Reckitt name, is a global consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets branded products intended to support personal health, household cleanliness and everyday hygiene.
Its portfolio includes consumer health brands such as Nurofen, Strepsils, Gaviscon, Mucinex and Durex, as well as hygiene and household brands including Dettol, Lysol, Finish and Harpic. Reckitt sells products through pharmacies, supermarkets, mass retailers, e-commerce platforms and other distribution channels.
The company was formed in 1999 through the merger of the British household-products manufacturer Reckitt & Colman and the Dutch company Benckiser.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.